PDF herunterladen
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2013; 34(03): 168-171
DOI: 10.4103/0971-5851.123717
ORIGINAL ARTICLE

Report of chronic myelogenous leukemia in chronic phase from, Asian Institute of Oncology, Mumbai, 2002-2010

Shweta Bansal
Department of Medical Oncology, Asian Institute of Oncology, S. L. Raheja Hospital, Mahim, Mumbai, Maharashtra, India
,
S.H. Advani
Department of Medical Oncology, Asian Institute of Oncology, S. L. Raheja Hospital, Mahim, Mumbai, Maharashtra, India
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
  als PDF herunterladen Lizenzen und Reprints

Abstract

Chronic myeloid leukemia (CML) has paradigm shift in its treatment modality after the discovery of targeted therapy Imatinib. At our centre we collected data of 100 consecutive patients over a period of 8 years. The interesting finding in our study was difference in the survival of patients presenting in early chronic phase (81%) versus late chronic phase (16%). Also the patients with primary resistance did poorly compared to the patients who developed secondary resistance to Imatinib.

Keywords

Chronic myeloid leukemia - chronic phase - veenat - Glivec


Publikationsverlauf

Artikel online veröffentlicht:
19. Juli 2021

© 2013. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Lee SJ. Chronic myelogenous leukaemia. Br J Haematol 2000;111:993-1009.
  • 2 Cortes J. Natural history and staging of chronic myelogenous leukemia. Hematol Oncol Clin North Am 2004;18:569-84.
  • 3 Pinilla- Ibarz J, Bello C. Modern approaches to treating chronic myelogenous leukemia. Curr Oncol Rep 2008;10:365-71.